AntimetabolitesAntimetabolites, AntineoplasticAntineoplastic AgentsTetrahydrouridinePyrimidinesAntineoplastic Combined Chemotherapy ProtocolsFloxuridineTrabeculectomyPyrimidine NucleotidesFluorouracil6-MercaptopurineMethotrexatePyrimidine DimersMitomycinCytarabineDeoxycytidineSurgical SpongesNeoplasmsLeukemia L1210Pyrimidine NucleosidesChemotherapy, AdjuvantThioguanineDrug Screening Assays, AntitumorInosine MonophosphatePhosphoribosyl PyrophosphateDrug SynergismVidarabine PhosphateCell SurvivalPurinesDoxorubicinTumor Cells, Cultured6-AminonicotinamideCisplatinFolic Acid AntagonistsPantothenic AcidNorleucineCell Line, TumorCell DivisionThymidylate SynthaseDrug Resistance, NeoplasmApoptosisCombined Modality TherapyPhosphonoacetic AcidDrug Evaluation, PreclinicalEtoposideGuanineCyclophosphamideCell LineAntineoplastic Agents, PhytogenicCell CycleTreatment OutcomeAntibiotics, AntineoplasticBreast NeoplasmsPaclitaxelAzathioprineLung NeoplasmsDeoxyribonuclease (Pyrimidine Dimer)Neoadjuvant TherapyPyrimidine PhosphorylasesUracilKineticsDisease-Free SurvivalDrug Delivery SystemsCamptothecinOrotic AcidVinblastineOrganoplatinum CompoundsUltraviolet RaysStreptomycesOrotate PhosphoribosyltransferaseDrug Administration ScheduleSurvival AnalysisDose-Response Relationship, DrugNeoplasm StagingCarboplatinPrognosisBleomycinTaxoidsDrug CarriersXenograft Model Antitumor AssaysSurvival RateMolecular StructureDNA DamageAntineoplastic Agents, AlkylatingMice, NudeP-GlycoproteinDNA RepairDrug Resistance, MultipleDNACell ProliferationDaunorubicinDihydroorotaseDeoxyribodipyrimidine Photo-LyaseAnthracyclinesInhibitory Concentration 50Time FactorsUridineMitoxantroneOvarian NeoplasmsEllipticines